EMJ Neurology 13 [Supplement 5] . 2025

In this issue

Generalised myasthenia gravis (gMG) is a rare and chronic IgG-mediated autoimmune neuromuscular disease that causes fluctuating and unpredictable muscle weakness. Standard treatment of gMG has traditionally included symptomatic therapy with acetylcholine esterase inhibitors such as pyridostigmine and disease-modifying treatments including steroids, as well as steroid-sparing immunosuppressants and thymectomy.